Delivering inhaled corticosteroids to patients.
作者信息
O'Callaghan C, Barry P
出版信息
BMJ. 1999 Feb 13;318(7181):410-1. doi: 10.1136/bmj.318.7181.410.
Abstract
摘要
相似文献
1
Delivering inhaled corticosteroids to patients.为患者提供吸入性糖皮质激素。
BMJ. 1999 Feb 13;318(7181):410-1. doi: 10.1136/bmj.318.7181.410.
2
Potential adverse effects of the inhaled corticosteroids.吸入性糖皮质激素的潜在不良反应。
J Allergy Clin Immunol. 2004 Apr;113(4):788; author reply 788-9. doi: 10.1016/j.jaci.2004.01.759.
3
Bone turnover and inhaled corticosteroids.骨转换与吸入性糖皮质激素
Thorax. 1995 Jan;50(1):103. doi: 10.1136/thx.50.1.103.
4
A rare case of adrenal insufficiency induced by inhaled corticosteroids.吸入性糖皮质激素诱发肾上腺功能不全的罕见病例。
J Am Geriatr Soc. 2013 May;61(5):841-2. doi: 10.1111/jgs.12241.
5
Inhaled corticosteroids: benefits and risks.吸入性糖皮质激素：益处与风险。
Thorax. 1992 Jun;47(6):404-7. doi: 10.1136/thx.47.6.404.
6
Weaning from inhaled corticosteroids in COPD: the evidence.慢性阻塞性肺疾病中吸入性糖皮质激素的撤药：证据
Eur Respir J. 2015 Nov;46(5):1232-5. doi: 10.1183/13993003.00282-2015.
7
A renewed focus on safety, efficacy, and use of inhaled corticosteroids in asthma.对哮喘中吸入性糖皮质激素的安全性、有效性及使用的重新关注。
Ann Allergy Asthma Immunol. 2016 Dec;117(6):575-576. doi: 10.1016/j.anai.2016.04.012.
8
Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society.
Eur Respir J. 1998 May;11(5):1194-210. doi: 10.1183/09031936.98.11051194.
9
Weighing the benefits and risks of inhaled corticosteroids.权衡吸入性糖皮质激素的利弊。
Curr Opin Pulm Med. 2007 Mar;13(2):89. doi: 10.1097/MCP.0b013e328042bb0c.
10
Adverse effects of inhaled corticosteroids.吸入性糖皮质激素的不良反应。
BMJ. 1989 Feb 18;298(6671):403-4. doi: 10.1136/bmj.298.6671.403.
引用本文的文献
1
Deposition and effects of inhaled corticosteroids.吸入性糖皮质激素的沉积与作用
Clin Pharmacokinet. 2003;42(6):529-44. doi: 10.2165/00003088-200342060-00003.
2
Pectus excavatum: studiously ignored in the United Kingdom?漏斗胸：在英国被刻意忽视了吗？
Arch Dis Child. 2000 Mar;82(3):187-8. doi: 10.1136/adc.82.3.187.
3
How to choose delivery devices for asthma.如何选择哮喘的给药装置
Arch Dis Child. 2000 Mar;82(3):185-7. doi: 10.1136/adc.82.3.185.
4
Spacer devices increase dose of inhaled corticosteroids delivered.储雾罐装置可增加吸入糖皮质激素的给药剂量。
BMJ. 1999 Jun 26;318(7200):1764. doi: 10.1136/bmj.318.7200.1764.
本文引用的文献
1
Use of inhaled corticosteroids and the risk of cataracts.吸入性糖皮质激素的使用与患白内障的风险
N Engl J Med. 1997 Jul 3;337(1):8-14. doi: 10.1056/NEJM199707033370102.
2
Spacer devices in the treatment of asthma.用于哮喘治疗的储雾罐装置
BMJ. 1997 Apr 12;314(7087):1061-2. doi: 10.1136/bmj.314.7087.1061.
3
Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices.两种雾化器和两种间距装置产生的二丙酸倍氯米松的粒径
Thorax. 1990 Feb;45(2):109-11. doi: 10.1136/thx.45.2.109.
4
Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?大容量储雾罐装置能否降低高剂量吸入性糖皮质激素的全身效应？
Thorax. 1990 Oct;45(10):736-9. doi: 10.1136/thx.45.10.736.
5
Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.容积雾化储器和漱口对定量气雾剂及干粉吸入器中吸入性糖皮质激素全身吸收的影响。
Thorax. 1991 Dec;46(12):891-4. doi: 10.1136/thx.46.12.891.
Zotero 插件